Announcements Trials

Browse Landscape

Clinical Trials

1 trials

Recent Start date Enrollment

Histiocytosis × Panitumumab × CNS × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1 Myeloid 1 Head & Neck 1 Gastrointestinal 1 CNS 1

Conditions

Glioma 2 Brain Neoplasms 2 Thyroid Neoplasms 1 Lung Neoplasms 1 Histiocytosis 1 Gliosarcoma 1 Glioblastoma 1 Colorectal Neoplasms 1 Carcinoma, Non-Small-Cell Lung 1

Interventions

Panitumumab 1 IFL protocol 1 Gemcitabine 1 Cetuximab 1 130-nm albumin-bound paclitaxel 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05786924 2026-04-21

Phase 1/2 Trial of S241656 in Selected RAS/MAPK Mutation- Positive Malignancies

Servier

Phase 1/2 Recruiting

CNSGastrointestinalHead & NeckMyeloidThoracic

Brain Neoplasms, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Thyroid Neoplasms, Colorectal Neoplasms, Histiocytosis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡